Grafimedics SRL
2.3 FTEThe score of Grafimedics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets +32 % Headcount (avg FTE) +15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Grafimedics's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Oct 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Grafimedics's financial analysis
- Solvency24.3%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Grafimedics
Grafimedics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0462.595.473
- VAT number
- BE0462595473
- Peppol
- Registered · 0208:0462595473 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Feb 1998
- Registered office
- 9810 Nazareth-De Pinte
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 14 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Grafimedics (SRL) has been based in Nazareth-De Pinte since 1998, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 26,584 € and equity of 383,947 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 24.3%, below the median of its sector (46.0%).
Companies similar to Grafimedics
Companies in the same business, of comparable size and area, outside its group.
- Ophtalmo Vision Care Wholesale of pharmaceutical and medical goods Oudenaarde · balance sheet €1.41m
- PRO Scan Manufacture of medical and dental instruments and supplies Zonhoven · balance sheet €2.83m
- Aagato Medical Wholesale of pharmaceutical and medical goods Ghent · balance sheet €3.86m
- Motion Medical Holding Manufacture of medical and dental instruments and supplies Les Bons Villers · balance sheet €4.44m
- Pharmentum Manufacture of pharmaceutical preparations Kontich · balance sheet €1.94m
- Orthomedics Wholesale of pharmaceutical and medical goods Wetteren · balance sheet €1.43m
- Alexo Wholesale of pharmaceutical and medical goods Ham-sur-Heure-Nalinnes · balance sheet €1.45m
- D.I. Wholesale of pharmaceutical and medical goods Anzegem · balance sheet €3.69m
Frequently asked questions about Grafimedics
What is the revenue of Grafimedics?
Grafimedics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Grafimedics?
In Belgium, the VAT number is the company number prefixed with BE: BE0462595473 for Grafimedics, if the company is VAT-registered. Its company number (CBE) is 0462.595.473.
Where is the registered office of Grafimedics?
According to the CBE register, the registered office of Grafimedics is in 9810 Nazareth-De Pinte.
What is the equity of Grafimedics?
At the close of the 2025 financial year, the equity of Grafimedics amounts to 383,947 €, a solvency of 24.3% of total assets.
How many people work at Grafimedics?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Grafimedics?
The register lists 2 active mandates at Grafimedics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Grafimedics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →